EPC development in the bone marrow and their mobilization to the blood was impaired in CCL2−/−HER2/neu mice compared with WT HER2/neu mice, providing a possible mechanism for the observed anti-tumor phenotype (71). This evidence concerns the gene ERBB2 and neoplasm.